Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 23, 2017 Filed Oct 25, 2017 20:45 UTC |
Mulham David MulhamChief Field Development Office
|
GrantRestricted Stock Units · Derivative | 2,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013435 · edgar.xml · derivative · entry 1 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,047 Underlying: Common Stock · 2,555 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 20:43 UTC |
Bramble JamesChief Legal Officer and Sec
|
GrantRestricted Stock Units · Derivative | 2,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013434 · edgar.xml · derivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Officer and Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,549 Underlying: Common Stock · 2,549 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 20:42 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
GrantRestricted Stock Units · Derivative | 2,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013433 · edgar.xml · derivative · entry 1 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,198 Underlying: Common Stock · 2,198 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 20:42 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 2,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013432 · edgar.xml · derivative · entry 1 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,309 Underlying: Common Stock · 2,309 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 20:41 UTC |
Noot WalterChief Information Officer
|
GrantRestricted Stock Units · Derivative | 2,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013431 · edgar.xml · derivative · entry 1 Noot Walter · CIK 0001691991 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,525 Underlying: Common Stock · 2,525 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 20:38 UTC |
Guest KevinC.E.O.
|
GrantRestricted Stock Units · Derivative | 7,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013430 · edgar.xml · derivative · entry 1 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,831 Underlying: Common Stock · 7,338 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 20:36 UTC |
Nixon J ScottDirector
|
GrantDeferred Stock Unit · Derivative | 859 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013429 · edgar.xml · derivative · entry 1 Nixon J Scott · CIK 0001709352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 859 Underlying: Common Stock · 859 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted. F2 · derivative.exercise_date: Following termination of the undersigned's service on the issuer's Board of Directors, the issuer will distribute to the undersigned shares of common stock equal to the number of DSU's granted. F2 · derivative.expiration_date: Following termination of the undersigned's service on the issuer's Board of Directors, the issuer will distribute to the undersigned shares of common stock equal to the number of DSU's granted. Read SEC document |
| October 03, 2017 Filed Oct 4, 2017 15:53 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 13,851 | $57.59 | $797,744.19 |
DisclosureSEC source: 0001179110-17-013066 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,150,138 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $56.80 to $58.00, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 03, 2017 Filed Oct 4, 2017 15:52 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 13,851 | $57.59 | $797,744.19 |
DisclosureSEC source: 0001179110-17-013065 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,150,138 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $56.80 to $58.00, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 15:53 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 26,149 | $57.51 | $1,503,849.91 |
DisclosureSEC source: 0001179110-17-013066 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,163,989 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $56.375 to $57.80, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 15:52 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 26,149 | $57.51 | $1,503,849.91 |
DisclosureSEC source: 0001179110-17-013065 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,163,989 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $56.375 to $57.80, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 21:28 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 28,788 | $57.19 | $1,646,515.27 |
DisclosureSEC source: 0001179110-17-012335 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,190,138 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $57.00 to $57.45, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 21:27 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 28,788 | $57.19 | $1,646,515.27 |
DisclosureSEC source: 0001179110-17-012333 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,190,138 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $57.00 to $57.45, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 14, 2017 Filed Sep 14, 2017 21:45 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 34,226 | $57.51 | $1,968,258.54 |
DisclosureSEC source: 0001179110-17-012300 · edgar.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,218,926 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $57.40 to $557.65, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 14, 2017 Filed Sep 14, 2017 21:44 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 34,226 | $57.51 | $1,968,258.54 |
DisclosureSEC source: 0001179110-17-012299 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,218,926 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $57.40 to $57.65, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 14, 2017 Filed Sep 15, 2017 21:29 UTC Amendment |
WENTZ MYRON WDirector
|
SaleCommon Stock | 34,226 | $57.51 | $1,968,258.54 |
DisclosureSEC source: 0001179110-17-012336 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,218,926 F1 · price: Footnote 4 on the Form 4 filed 09/14/2017 disclosed an incorrect price range of $57.40 to $557.65. The actual price range in multiple transactions is $57.40 to $57.65. Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 21:45 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 18,861 | $57.39 | $1,082,421.47 |
DisclosureSEC source: 0001179110-17-012300 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,253,152 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $57.20 to $58.00, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 21:44 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 18,861 | $57.39 | $1,082,421.47 |
DisclosureSEC source: 0001179110-17-012299 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,253,152 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $57.20 to $58.00, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 21:45 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 26,207 | $57.91 | $1,517,584.47 |
DisclosureSEC source: 0001179110-17-012300 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,272,013 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $57.80 to $58.35, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 21:44 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 26,207 | $57.91 | $1,517,584.47 |
DisclosureSEC source: 0001179110-17-012299 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,272,013 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $57.80 to $58.35, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 18:03 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 28,004 | $58.23 | $1,630,560.90 |
DisclosureSEC source: 0001179110-17-012058 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,298,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $57.625 to $58.90, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 18:02 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 28,004 | $58.23 | $1,630,560.90 |
DisclosureSEC source: 0001179110-17-012057 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,298,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $57.625 to $58.90, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| September 05, 2017 Filed May 26, 2018 00:30 UTC |
WENTZ MYRON WDirector
|
GiftCommon Stock | 136,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-031181 · tv495187_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,025,753 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| September 05, 2017 Filed May 26, 2018 00:28 UTC |
Gull Global Ltd10% owner
|
GiftCommon Stock | 136,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-031180 · tv495185_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,025,753 Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 18:03 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 11,996 | $58.83 | $705,740.27 |
DisclosureSEC source: 0001179110-17-012058 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,326,224 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $58.50 to $59.30, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 18:02 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 11,996 | $58.83 | $705,740.27 |
DisclosureSEC source: 0001179110-17-012057 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,326,224 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $58.50 to $59.30, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| August 30, 2017 Filed Aug 30, 2017 21:38 UTC |
Macuga Daniel A.Chief Communications Officer
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 23,436 | $0.00 Strike: $28.81 | $0.00 |
DisclosureSEC source: 0001179110-17-011896 · edgar.xml · derivative · entry 3 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,436 shares Expires 2018-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2017 Filed Aug 30, 2017 21:38 UTC |
Macuga Daniel A.Chief Communications Officer
|
SaleCommon Stock | 11,992 | $59.00 | $707,528.00 |
DisclosureSEC source: 0001179110-17-011896 · edgar.xml · nonDerivative · entry 2 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 30, 2017 Filed Aug 30, 2017 21:38 UTC |
Macuga Daniel A.Chief Communications Officer
|
Exercise / conversionCommon Stock | 11,992 | $28.81 | $345,489.52 |
DisclosureSEC source: 0001179110-17-011896 · edgar.xml · nonDerivative · entry 1 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 20:24 UTC |
Macuga Daniel A.Chief Communications Officer
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 7,068 | $0.00 Strike: $28.81 | $0.00 |
DisclosureSEC source: 0001179110-17-011876 · edgar.xml · derivative · entry 6 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,436 Underlying: Common Stock · 7,068 shares Expires 2018-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 20:24 UTC |
Macuga Daniel A.Chief Communications Officer
|
SaleCommon Stock | 3,674 | $60.00 | $220,440.00 |
DisclosureSEC source: 0001179110-17-011876 · edgar.xml · nonDerivative · entry 4 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 20:24 UTC |
Macuga Daniel A.Chief Communications Officer
|
Exercise / conversionCommon Stock | 3,674 | $28.81 | $105,847.94 |
DisclosureSEC source: 0001179110-17-011876 · edgar.xml · nonDerivative · entry 3 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 20:24 UTC |
Macuga Daniel A.Chief Communications Officer
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 3,996 | $0.00 Strike: $28.81 | $0.00 |
DisclosureSEC source: 0001179110-17-011876 · edgar.xml · derivative · entry 5 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,504 Underlying: Common Stock · 3,996 shares Expires 2018-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 20:24 UTC |
Macuga Daniel A.Chief Communications Officer
|
SaleCommon Stock | 2,077 | $60.00 | $124,620.00 |
DisclosureSEC source: 0001179110-17-011876 · edgar.xml · nonDerivative · entry 2 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 20:24 UTC |
Macuga Daniel A.Chief Communications Officer
|
Exercise / conversionCommon Stock | 2,077 | $28.81 | $59,838.37 |
DisclosureSEC source: 0001179110-17-011876 · edgar.xml · nonDerivative · entry 1 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| August 23, 2017 Filed Aug 23, 2017 20:45 UTC |
Brown JimPresident & COO
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 7,541 | $0.00 Strike: $28.81 | $0.00 |
DisclosureSEC source: 0001179110-17-011777 · edgar.xml · derivative · entry 9 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,541 shares Expires 2018-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2017 Filed Aug 23, 2017 20:45 UTC |
Brown JimPresident & COO
|
SaleCommon Stock | 3,859 | $59.00 | $227,681.39 |
DisclosureSEC source: 0001179110-17-011777 · edgar.xml · nonDerivative · entry 6 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Weighted average price $59.0001. Price range in multiple transactions was $59.00 to $59.25 inclusively. Read SEC document |
| August 23, 2017 Filed Aug 23, 2017 20:45 UTC |
Brown JimPresident & COO
|
Exercise / conversionCommon Stock | 3,859 | $28.81 | $111,177.79 |
DisclosureSEC source: 0001179110-17-011777 · edgar.xml · nonDerivative · entry 5 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| August 23, 2017 Filed Aug 23, 2017 20:46 UTC |
Guest KevinC.E.O.
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 37,884 | $0.00 Strike: $28.81 | $0.00 |
DisclosureSEC source: 0001179110-17-011778 · edgar.xml · derivative · entry 6 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,884 shares Expires 2018-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2017 Filed Aug 23, 2017 20:46 UTC |
Guest KevinC.E.O.
|
SaleCommon Stock | 19,385 | $59.02 | $1,144,025.16 |
DisclosureSEC source: 0001179110-17-011778 · edgar.xml · nonDerivative · entry 4 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Weighted average price $59.016. Price range in multiple transactions was $59.00 to $59.25 inclusively. Read SEC document |
| August 23, 2017 Filed Aug 23, 2017 20:46 UTC |
Guest KevinC.E.O.
|
Exercise / conversionCommon Stock | 19,385 | $28.81 | $558,481.85 |
DisclosureSEC source: 0001179110-17-011778 · edgar.xml · nonDerivative · entry 3 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 20:45 UTC |
Brown JimPresident & COO
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 20,599 | $0.00 Strike: $28.81 | $0.00 |
DisclosureSEC source: 0001179110-17-011777 · edgar.xml · derivative · entry 8 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,541 Underlying: Common Stock · 20,599 shares Expires 2018-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 20:45 UTC |
Brown JimPresident & COO
|
SaleCommon Stock | 10,540 | $59.00 | $621,860.00 |
DisclosureSEC source: 0001179110-17-011777 · edgar.xml · nonDerivative · entry 4 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 20:45 UTC |
Brown JimPresident & COO
|
Exercise / conversionCommon Stock | 10,540 | $28.81 | $303,657.40 |
DisclosureSEC source: 0001179110-17-011777 · edgar.xml · nonDerivative · entry 3 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 20:46 UTC |
Guest KevinC.E.O.
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 20,616 | $0.00 Strike: $28.81 | $0.00 |
DisclosureSEC source: 0001179110-17-011778 · edgar.xml · derivative · entry 5 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,884 Underlying: Common Stock · 20,616 shares Expires 2018-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 20:46 UTC |
Guest KevinC.E.O.
|
SaleCommon Stock | 10,549 | $59.00 | $622,391.00 |
DisclosureSEC source: 0001179110-17-011778 · edgar.xml · nonDerivative · entry 2 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 20:46 UTC |
Guest KevinC.E.O.
|
Exercise / conversionCommon Stock | 10,549 | $28.81 | $303,916.69 |
DisclosureSEC source: 0001179110-17-011778 · edgar.xml · nonDerivative · entry 1 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II. Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 15:58 UTC |
Bramble JamesChief Legal Officer and Sec
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 37,000 | $0.00 Strike: $28.81 | $0.00 |
DisclosureSEC source: 0001179110-17-011721 · edgar.xml · derivative · entry 3 Bramble James · CIK 0001441438 · Chief Legal Officer and Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,000 shares Expires 2018-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 15:58 UTC |
Bramble JamesChief Legal Officer and Sec
|
SaleCommon stock | 18,298 | $57.01 | $1,043,254.98 |
DisclosureSEC source: 0001179110-17-011721 · edgar.xml · nonDerivative · entry 2 Bramble James · CIK 0001441438 · Chief Legal Officer and Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,076 F2 · price: Weighted average price $57.0147. Price range in multiple transactions was $57.00 to $57.30 inclusively. Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 15:58 UTC |
Bramble JamesChief Legal Officer and Sec
|
Exercise / conversionCommon Stock | 18,298 | $28.81 | $527,165.38 |
DisclosureSEC source: 0001179110-17-011721 · edgar.xml · nonDerivative · entry 1 Bramble James · CIK 0001441438 · Chief Legal Officer and Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-setteld stock appreciation rights disclosed in Table-II Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.